Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Low level anti-Hu reactivity: A risk marker for small cell lung cancer?

Tsou JA, Kazarian M, Patel A, Galler JS, Laird-Offringa IA, Carpenter CL, London SJ.

Cancer Detect Prev. 2009;32(4):292-9. doi: 10.1016/j.cdp.2008.06.006. Epub 2008 Dec 12.

2.

Immune response in lung cancer mouse model mimics human anti-Hu reactivity.

Kazarian M, Calbo J, Proost N, Carpenter CL, Berns A, Laird-Offringa IA.

J Neuroimmunol. 2009 Dec 10;217(1-2):38-45. doi: 10.1016/j.jneuroim.2009.08.014. Epub 2009 Sep 17.

3.

Paraneoplastic sensorimotor neuropathy associated with regression of small cell lung carcinoma.

Mawhinney E, Gray OM, McVerry F, McDonnell GV.

BMJ Case Rep. 2010 Oct 3;2010. pii: bcr0120091486. doi: 10.1136/bcr.01.2009.1486.

4.

Anti-Hu Positive Antibodies and Small Cell Carcinoma: A Single Center Review.

List M, Jamous F, Gupta A, Huntington M.

S D Med. 2015 Jun;68(6):251, 253-5.

PMID:
26137725
5.

Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer.

Sabater L, Höftberger R, Boronat A, Saiz A, Dalmau J, Graus F.

PLoS One. 2013;8(3):e60438. doi: 10.1371/journal.pone.0060438. Epub 2013 Mar 25.

6.

Molecular detection of neuron-specific ELAV-like-positive cells in the peripheral blood of patients with small-cell lung cancer.

D'Alessandro V, Muscarella LA, Copetti M, Zelante L, Carella M, Vendemiale G.

Cell Oncol. 2008;30(4):291-7.

7.

Small Cell Lung Cancer Accompanied by Tonsillar Metastasis and Anti-Hu Antibody-Associated Paraneoplastic Neuropathy: A Rare Case Report With Long-Term Survival.

Ni J, Weng L, Liu M, Yang H, Wang Y.

Medicine (Baltimore). 2015 Dec;94(50):e2291. doi: 10.1097/MD.0000000000002291.

8.

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

Graus F, Dalmou J, Reñé R, Tora M, Malats N, Verschuuren JJ, Cardenal F, Viñolas N, Garcia del Muro J, Vadell C, Mason WP, Rosell R, Posner JB, Real FX.

J Clin Oncol. 1997 Aug;15(8):2866-72.

PMID:
9256130
9.

Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer.

Verschuuren JJ, Perquin M, ten Velde G, De Baets M, Vriesman PB, Twijnstra A.

J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):353-7.

10.

SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.

Titulaer MJ, Klooster R, Potman M, Sabater L, Graus F, Hegeman IM, Thijssen PE, Wirtz PW, Twijnstra A, Smitt PA, van der Maarel SM, Verschuuren JJ.

J Clin Oncol. 2009 Sep 10;27(26):4260-7. doi: 10.1200/JCO.2008.20.6169. Epub 2009 Aug 10.

PMID:
19667272
11.

Limbic encephalitis and small cell lung cancer. Clinical and immunological features.

Alamowitch S, Graus F, Uchuya M, Reñé R, Bescansa E, Delattre JY.

Brain. 1997 Jun;120 ( Pt 6):923-8.

PMID:
9217677
12.

Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma.

Kiers L, Altermatt HJ, Lennon VA.

Mayo Clin Proc. 1991 Dec;66(12):1209-16.

PMID:
1660950
13.

Spontaneous complete remission of a non-small cell lung cancer associated with anti-Hu antibody syndrome.

Pujol JL, Godard AL, Jacot W, Labauge P.

J Thorac Oncol. 2007 Feb;2(2):168-70.

14.

Anti-HuC and -HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung.

Matsumoto T, Ryuge S, Kobayashi M, Kageyama T, Hattori M, Goshima N, Jiang SX, Saegusa M, Iyoda A, Satoh Y, Masuda N, Sato Y.

Int J Oncol. 2012 Jun;40(6):1957-62. doi: 10.3892/ijo.2012.1405. Epub 2012 Mar 16.

PMID:
22426972
15.

Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.

Gozzard P, Chapman C, Vincent A, Lang B, Maddison P.

PLoS One. 2015 Nov 25;10(11):e0143558. doi: 10.1371/journal.pone.0143558. eCollection 2015.

16.

Application of Serum ELAVL4 (HuD) Antigen Assay for Small Cell Lung Cancer Diagnosis.

Wang F, Lu J, Li S, Huo X, Liu X, Du X, Li C, Wang J, Chen Z.

Anticancer Res. 2017 Aug;37(8):4515-4522.

PMID:
28739747
17.

Pattern of epitopic reactivity of the anti-Hu antibody on HuD with and without paraneoplastic syndrome.

Sodeyama N, Ishida K, Jaeckle KA, Zhang L, Azuma A, Yamada M, Mizusawa H, Wada Y.

J Neurol Neurosurg Psychiatry. 1999 Jan;66(1):97-9.

18.

Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci.

Krug LM, Ragupathi G, Hood C, George C, Hong F, Shen R, Abrey L, Jennings HJ, Kris MG, Livingston PO.

Cancer Immunol Immunother. 2012 Jan;61(1):9-18. doi: 10.1007/s00262-011-1083-6. Epub 2011 Aug 3.

19.

Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer.

Akın Kabalak P, Çiledağ A, Demir N, Çelik G, Yüksel C, Köycü G, Gökmen Öztuna D, Taner A, Kaya A, Kutlay H, Numanoğlu N, Savaş İ.

Tuberk Toraks. 2015 Jun;63(2):71-7.

20.

Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells.

Roberts WK, Deluca IJ, Thomas A, Fak J, Williams T, Buckley N, Dousmanis AG, Posner JB, Darnell RB.

J Clin Invest. 2009 Jul;119(7):2042-51. doi: 10.1172/JCI36131. Epub 2009 Jun 8.

Supplemental Content

Support Center